Skip to main content
Premium Trial:

Request an Annual Quote

Belgian Firm Galapagos Genomics to Build Adenoviruses for Bayer

NEW YORK, July 10 - Belgian genomics firm Galapagos Genomics said today it will use its PhenoSelect gene-expression tool to build recombinant adenoviruses for Bayer.

 

Through the deal, an expansion of an agreement signed in June 2001, Galapagos will help Bayer perform in vivo validation studies based  on its undisclosed human genes. The drug giant said it plans to use the adenoviruses to express newly found genes in animal models to study corresponding proteins.

 

Click here for more information.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.